申请人:G.D. Searle & Co.
公开号:US05990326A1
公开(公告)日:1999-11-23
The present invention relates to compounds of the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein R is alkyl of 12 carbon atoms, alkenyl of 12 carbon atoms having from 1 to 4 --CH.dbd.CH-- groups when the carbon adjacent to R is saturated and from 1 to 2 --CH.dbd.CH-- groups when the carbon adjacent to R is unsaturated, aryl, heterocyclo, alkoxyalkyl wherein the alkyl groups have 1 to 6 carbon atoms, or aryloxyalkyl wherein the alkyl group has 1 to 6 carbon atoms R.sup.1 is hydrogen, lower alkyl, or a pharmaceutically acceptable cation. These compounds are inhibitors of leukotriene A.sub.4 (LTA.sub.4) hydrolase.
本发明涉及下列公式的化合物## STR1 ##或其药学上可接受的盐,其中R是12个碳原子的烷基,具有1到4个—CH = CH—基团,当靠近R的碳饱和时,具有1到2个—CH = CH—基团,当靠近R的碳不饱和时,芳香族,杂环烷基,烷氧基烷基,其中烷基含有1到6个碳原子,或芳氧基烷基,其中烷基含有1到6个碳原子R1是氢,低烷基或药学上可接受的阳离子。这些化合物是白三烯A4(LTA4)水解酶的抑制剂。